Register For UpdatesAbout IC-HEP

Registration

Back to links
Back to links

Global Education

VIEW WEBCAST

LAUNCH DATE
05/18/2017
EXPIRATION DATE
05/18/2018

1.0
CREDIT

Target Audience

This activity was developed for gastroenterologists and hepatologists and other healthcare providers managing patients with HCV.

Educational Objectives

Upon completion of this activity, the participants should be better able to:

  • Describe evolving treatment strategies for chronic hepatitis C
  • Apply the most recent safety findings relating to hepatitis C patient management to clinical practice

ACCME ACCREDITATION STATEMENT (PHYSICIANS):

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and IC-HEP. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC ACCREDITATION STATEMENT (NURSES):

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.0 contact hours may be earned for successful completion of this activity.

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and IC-HEP have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosures

Jasmohan Bajaj, MD

Jasmohan Bajaj disclosed that he has participated on advisory boards for Valeant, Norgine, and Grifols. Dr. Bajaj is part of the editorial board for the American Journal of Gastroenterology, Hepatology, J Hepatol, and Liver Transplantation.

Rajender Reddy, MD

Rajender Reddy, MD disclosed that he has received grants and research support from BMS, Gilead, Merck, Janssen, and AbbVie (paid to the institution). Dr. Reddy has also served on an advisory board for BMS, Gilead, Merck, Janssen, and AbbVie.

Speakers

Jasmohan Bajaj, MD

Virginia Commonwealth University and
McGuire VA Medical Center
Richmond, Virginia, USA

Rajender Reddy, MD

University of Philadelphia
Philadelphia, Pennsylvania, USA

Webcast

The webcast must be viewed in its
entirety to claim credit.

Accredited by

This enduring activity is supported
educational grants from:

AbbVie & Gilead Sciences, Inc.